However, "significant bottlenecks still exist," according to Dominika Suchonova, a spokesperson for MedTech Europe, a European association that represents IVD and medical device makers. Suchonova ...

The updated CE marking now enables labs in Europe to unify their workflows for both cell and tissue slide imaging and processing.

Designed for routine clinical use, the system can identify M-proteins based on their molecular weight to help diagnose multiple myeloma and related disorders.

Legislation passed by the US Senate to reopen the federal government includes a temporary delay to price cuts and data reporting requirements.

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...

The company said that recent study results show its Aventa Lymphoma test can provide actionable information that would typically be missed by FISH testing.

The El Monte, California, lab services provider increased its full-year 2025 guidance for both its revenues and its adjusted earnings.

These drugs, which are among the most common types of blood thinners, can interfere with traditional coagulation tests, producing unreliable results.

Parent firm Siemens is considering reducing its ownership stake in Siemens Healthineers, which could mean the termination of existing financing agreements.

The Dublin-based firm is developing an array of artificial intelligence-derived tools to improve the efficiency of its digital pathology outsourcing service.

As a result of the firm's financial results, Castle Bio raised its full-year 2025 revenue guidance to between $327 and $335 million from a range of $310 to $320 million.